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Introduction
Our findings from a series of studies have led us to propose that 
abnormalities in the behaviour of mice with functional ablation 
of the NK1 (substance P-preferring) receptor gene, Nk1r, are 
analogous to those seen in attention deficit hyperactivity disorder 
(ADHD). This proposal is based on several lines of evidence.
First, comparisons of the locomotor behaviour of NK1R-/- 
mice and their wildtypes have revealed that the former genotype 
typically displays locomotor hyperactivity in a range of different 
experimental settings (Fisher et al., 2007; Herpfer et al., 2005; 
Moyes et al., 2016; Porter et al., 2015a, 2015b).
Secondly, in the 5-Choice Serial Reaction-Time Test 
(5CSRTT), NK1R-/- mice typically score more omission errors 
(an index of inattentiveness) and carry out a higher number of 
premature responses, which is an index of a form of (‘waiting’) 
impulsivity (e.g. Yan et al., 2011). By contrast, NK1R-/- mice did 
not express excessive ‘false alarms’ (another index of impulsive 
behaviour (response inhibition)) in the 5-Choice Continuous 
Performance Test (5C-CPT; Porter et al., 2016). However, these 
mice performed excessive perseverative responses in both the 
5CSRTT and the 5C-CPT (Pillidge et al., 2016; Yan et al., 2011): 
this behaviour is thought to reflect the repeated cognitive ‘check-
ing’ behaviour expressed by ADHD patients (Gürkan et al., 2015).
Thirdly, one, or more, of these behavioural abnormalities of 
NK1R-/- mice is ameliorated by all four compounds that are 
licensed for treatment of ADHD: guanfacine (inattentiveness: 
Pillidge et al., 2014a); atomoxetine (impulsivity (premature 
responses): Pillidge et al., 2014b); d-amphetamine and methyl-
phenidate (locomotor hyperactivity and perseveration: Pillidge 
et al., 2016; Yan et al., 2009, 2011).
Finally, evidence for an association between polymorphism(s) 
of the TACR1 gene in humans, which is equivalent to the Nk1r 
gene in mice, and ADHD has been replicated (e.g. Sharp et al., 
2014; Yan et al., 2010). This is interesting in light of associations 
between TACR1 with bipolar disorder (Sharp et al., 2014) and 
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alcoholism (Blaine et al., 2013), both of which show prominent 
comorbidity with ADHD.
On the basis of all this evidence, we have proposed that 
humans with TACR1 polymorphism(s) comprise an etiologically 
distinct subgroup of ADHD patients. However, when carrying 
out all these studies, we noted that NK1R-/- mice seemed smaller 
than their wildtypes. There are many reports of an association 
between small body size and ADHD (Ptacek et al., 2009; Spencer 
et al., 1996), which is evident even after exclusion of factors that 
are known to increase the risk of both ADHD and low birth 
weight (e.g. maternal smoking and alcohol misuse). In fact, evi-
dence from one case-controlled study of probands suggested that, 
as an independent risk factor for ADHD, low birth weight could 
account for at least 14% of all cases (Mick et al., 2002). Somewhat 
paradoxically, ADHD is also associated with a high body mass 
index (BMI) (Erhart et al., 2012; Hubel et al., 2006; Waring and 
Lapane, 2008; but see Curtin et al., 2005) that qualifies as obesity 
(BMI ⩾ 30 for adults or ⩾ 95th percentile for children) and which 
extends into adulthood (Cortese et al., 2013, 2016). This associa-
tion seems bidirectional because a high incidence of ADHD in 
obese individuals is also evident (Agranat-Meged et al., 2005; 
Altfas, 2002; Fleming et al., 2005). Furthermore, older children 
with ADHD have a higher tendency to be overweight, despite 
being smaller, than children without ADHD (Hanć et al., 2015).
Prompted by these findings, we compared body size, body 
mass and body composition of NK1R-/- and wildtype mice with 
the aim of determining whether or not these genetically-altered 
mice express physical abnormalities (small body size and excess 
body weight) that are more common in ADHD patients than com-
parator groups and which are regarded as risk factors for ADHD. 
Also, in view of evidence for sex differences in comorbid obe-
sity and ADHD (Byrd et al., 2013; Kim et al., 2011; Van Egmond-
Frohlich et al., 2012) we carried out these measurements on both 
male and female mice of both genotypes.
Materials and methods
All procedures complied with the Animals (Scientific Procedures) 
Act (UK) (2010/63/EU) and had received local ethical approval 
at University College London.
Animals
All the mice were bred at University College London and housed 
in a room held at 21 ± 2°C, 45 ± 5% humidity, with a 12/12 h 
light/dark cycle (lighting increased in steps from 07.00 to 08.00 h 
and decreased in steps from 19.00 to 20.00 h). Food and water 
were freely available at all times. We studied inbred homozygous 
mice because these mice express all the diagnostic abnormalities 
seen in ADHD (locomotor hyperactivity, impulsive behaviour, 
inattentiveness and perseveration). Hyperactivity, inattentiveness 
and perseveration are also evident in the homozygous (F2) off-
spring of heterozygote (F1) parents, but their impulsive behaviour 
arises from an interaction between a lack of functional NK1R and 
an, as yet unidentified, factor in the breeding environment (Porter 
et al., 2015b).
The study used a total of 77 age-matched, weanling mice 
(Cohort 1: 40; Cohort 2: 37). Differences in the litter sizes 
account for the unequal sample sizes of the two cohorts. The two 
genotypes (NK1R-/- and their wildtypes) derived from the same 
background colony of 129/Sv × C57BL/6J mice that were crossed 
with outbred MF1 mice more than ten generations ago (De Felipe 
et al., 1998). To avoid prolonged isolation of the mice in indi-
vidual cages, they were all group-housed as littermates (2–5 per 
cage). The home-cages incorporated environmental enrichment 
(cardboard tunnels and tissue for nesting material) and were 
cleaned twice weekly (bedding: 3Rs Bedding Pty, Ltd).
Study design 
Cohort 1 (normal diet): Male and female mice of the same geno-
type were randomly assigned to breeding pairs. Ten male and ten 
female pups of each genotype were weaned onto standard lab 
chow (18% of total calorific value derived from fat: 2018 global 
Rodent Diet, Harlan) at three weeks of age. At 6 weeks (±1 day) 
of age, their body length (nose to tail) was measured, under 
anaesthesia, before culling by cervical dislocation.
Cohort 2 (high-fat, ‘Western’ diet): A second batch of mice, 
from different breeding pairs and/or their litters, were weaned 
onto high-fat diet (45% of total calorific value derived from fat: 
Research Diets, NJ, USA) at 3 weeks of age. Every animal and 
the food remaining in each cage were weighed daily. The amount 
of food consumed per cage each day was corrected for the total 
weight of the mice within. After 28 days (i.e. at 7 weeks of age) 
the body length of the mice was measured, before they were 
culled, as before (see above). In this cohort, ‘Cage’ was treated as 
the experimental unit for measurements of food consumption. 
Measurement of body length could not be carried out ‘blind’ 
because the two genotypes have a different coat colour.
All carcasses were frozen at −20°C for subsequent chemical 
analysis of their fat, ash, protein and water content.
Chemical analysis
The procedures were based on those described by Eisen and 
Coffey (1990). In brief:
Water: All the carcasses were reweighed and frozen at −80°C 
for at least 5 h before freeze-drying (Heto PL9000) for 2 weeks at 
a shelf temperature of −25°C. The dried carcasses were then 
reweighed, to enable calculation of the water content of the car-
cass, and then stored in sealed jars in drying cabinets. Immediately 
before the chemical analysis, the dried carcasses were milled 
(Buchi Mixer B-400 homogeniser) and the samples analysed, as 
described below.
Ash: Approximately 1 g of each milled carcass was placed in 
a silica crucible and fired at 600°C for 6 h in a muffle ashing 
furnace (Carbolite, OAF 11/1) after which the cooled crucibles 
were reweighed. The residual ash content of each sample was 
weighed: the total ash content (g) of the original carcass was esti-
mated, from the original carcass weight, by extrapolation from 
the weight of ash in the sample.
Fat: Carcass fat content was determined by a modified 
Soxhlet extraction protocol. Samples of carcass (~1 g) were 
weighed into cellulose extraction thimbles (Whatman 26 mm × 
60 mm: 2800-266) and plugged with approximately 0.5 g of cot-
ton wool. Petroleum ether (90 mL, Fisher 40–60°C: P/1760/17) 
was used to extract the fat from each thimble using a Tecator 
Soxtec HT2 system (Foss, UK)/Tecator Soxtec 2050 system 
(Foss UK Ltd, Wheldrake, UK), with a modified manufacturer’s 
protocol (35 min extraction, 30 min wash and a 10 min drying 
period). After boiling the sample in the solvent, the fat was 
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extracted by evaporation and the weight of the extracted fat used 
to calculate the total fat content (g) of the original dried sample. 
The data for one subject (a female NK1R-/- mouse in Cohort 1) 
was excluded from the data-set due to partial spillage of the sam-
ple during the extraction process.
Protein: The protein content of the samples was calculated 
following measurement of their nitrogen content using the 
Kjeldahl assay. Using a Tecator 2012 (FOSS, UK) digestion 
block, approximately 0.3–0.4 g of each carcass sample was 
digested for 1 h at 420°C, in a mixture of 10 mL of concentrated 
sulphuric acid (Fisher S/9240/PB17), two Kjeltab CQ catalyst 
tablets (containing potassium sulphate and copper sulphate) and 
an antifoam S tablet (sodium sulphate and silicone antifoam, 
Thompson & Capper). A FOSS 2001 Scrubber Unit with sodium 
hydroxide solution and water was used to neutralize and remove 
any acidic waste gases. Subsequently, 40 mL of 10 M sodium 
hydroxide (Fisher J/7800/21) and 20 mL water were added to the 
cooled digested samples and steam was bubbled through indi-
vidual samples using a Tecator 2020 distilling unit / FOSS 2200 
Kjeltic Auto Distillation unit (FOSS, UK). Each sample was dis-
tilled into 30 mL of Kjeldahl receiver solution (4% boric acid with 
bromocresol green/methyl red indicator, Fisher K/0200/21). The 
addition of sodium hydroxide neutralized the acid and produced 
ammonia, which was ‘captured’ by distillation into the receiver 
solution. Each sample was then titrated with 0.1 M volumetric 
grade hydrochloric acid (Fisher J/4350/17): this enabled estima-
tion of the NH3+ content of the solution, which is proportional to 
the sample protein (amino acid) content.
Statistics
InVivoStat (version 3.2) was used for statistical analysis of 
the data (Bate and Clark, 2014; Clark et al., 2012). Data for 
Cohorts 1 and 2 were analysed separately. Diagnostic plots were 
constructed routinely to confirm normality of the raw data and 
homogeneity of sample variance. In only one case did apprecia-
ble deviation from normality make it necessary to transform 
the data-set (RANK transform (indicated in Results)) before 
proceeding with parametric analyses. Univariate analysis of 
variance (ANOVA) was used to analyse the overall effects of the 
main factors (Genotype and Sex), or their interaction, on body 
length, size and body composition. Pairs of data were compared 
using the post-hoc LSD test.
Differences in the time course for changes in body weight and 
food consumption for the two genotypes / sexes when fed the high-
fat diet were analysed using repeated measures ANOVA, with 
‘Genotype’ and ‘Sex’ as between-subjects factors and ‘Day’ as a 
within-subjects factor. ‘Mouse’ and ‘Cage’ were treated as the 
experimental units when analysing data for changes in body weight 
and food consumption, respectively (see above). For statistical 
analyses of food consumption, the sample numbers ((wildtypes) 
males (3)/females (2) and (NK1R-/-) males (3)/females (3)) were 
adequate for comparison of the main factors (Genotype and Sex), 
but not for assessment of any interaction between them.
Results
Body length
NK1R-/- mice from both cohorts were shorter, overall, than their 
wildtype counterparts (genotype: F(1,37) = 46.62, p < 0.0001 
(Cohort 1); F(1,33) = 9.52, p = 0.004 (Cohort 2)]. Only female 
NK1R-/- mice in Cohort 2, given the high-fat diet, were not 
shorter than their wildtypes (Figure 1(A)).
Body weight
NK1R-/- mice in Cohort 1 (i.e. fed the normal diet) weighed less, 
overall, than their wildtypes (genotype: F(1,36) = 6.21, p = 0.02), 
especially the males (LSD: p < 0.01). However, neither male nor 
female NK1R-/- mice in Cohort 2 weighed less than their 
wildtypes (Figure 1(B)).
Both genotypes of male mice weighed more than their females 
in both cohorts (F(1,36) = 46.38, p < 0.0001 (Cohort 1); F(1,33) = 
180.2, p < 0.0001 (Cohort 2)) (Figure 1(B)).
Body mass index (‘mBMI’)
By analogy with the use of BMI in humans as an index of body 
density, we calculated the ratio of body mass:body length (nose–
tail; cm)2 (‘mBMI’) for these mice. With the exception of males 
from Cohort 1, mBMI of NK1R-/- mice was higher than that of 
wildtypes (F(1,36) = 10.34, p < 0.01 (Cohort 1); F(1,33) = 20.6, p < 
0.0001 (Cohort 2)) and the mBMI of males was consistently 
higher than that of females (F(1,36) = 106.31, p < 0.001 (Cohort 1); 
F(1,33) = 158.6, p < 0.001 (Cohort 2)] (Figure 1(C)).
Changes in body weight and food eaten 
during 28 days of high-fat diet
There was no overall difference in the time course for the increase 
in body weight of the two genotypes which were fed the high-fat 
diet (Figure 2(a)). However, the body weight of males increased 
more quickly than the females, during 28 days of high-fat diet 
(sex*day: F(1,27) = 98.4, p < 0.0001]. The progressive increase in 
the weight of the males also persisted throughout the 28 days of 
the study, whereas the weight of the females tended to stabilise 
after approximately 2 weeks.
Despite these genotype and sex differences, the amount of 
food consumed by the mice was not affected by either genotype 
or sex, when this variable was corrected for the body weight of 
the mice (Figure 2(b)).
Fat (mg/g body weight)
In Cohort 1, there was no overall genotype difference in fat/g 
body weight. However, female, but not male, NK1R-/- mice had 
slightly less fat than their wildtypes ((–9%): geno*sex: F(1,35) = 
7.03, p < 0.05; post-hoc LSD: p = 0.03) (Figure 3(A)).
In the batch of animals fed the high-fat diet (Cohort 2), it is 
striking that the fat content of male NK1R-/- mice was consider-
ably higher than their male wildtypes ((+35%); geno*sex: F(1,33) = 
10.44, p < 0.01). Moreover, the fat content of male wildtypes was 
less than that of female wildtypes (sex: F(1,33) =12.22, p < 0.001; 
post-hoc LSD p < 0.0001], but there was no difference in the fat 
content of the two genotypes of female mice (Figure 3(B)).
Protein (mg/g body weight)
There was no difference in the amount of protein in the two 
genotypes from either cohort. However, there was an overall 
difference between the two sexes ((RANK transformed data): 
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F(1,36) = 8.56, p < 0.01 (Cohort 1); (raw data): F(1,33) = 37.71, p < 
0.01 (Cohort 2)) with females typically having slightly less pro-
tein (ca. 3%) than males (Figure 3(C, D)).
Ash (mg/g body weight)
There was no difference in the ash content of the two genotypes 
in either cohort (Figure 3(E and F)). However, female mice had a 
higher ash content than their males in both cohorts (F(1,36) = 
15.39, p = 0.001 (Cohort 1); F(1,36) = 39.5, p = 0.001 (Cohort 2)), 
especially in the NK1R-/- genotype (LSD: p < 0.001).
Water (mg/g body weight)
Neither genotype nor sex affected water content of mice from 
Cohort 1 (Figure 3(G)), but an overall difference between the 
two genotypes in Cohort 2 was of borderline significance (F(1,33) 
= 3.57, p = 0.067). Furthermore, in the latter cohort, there was 
a difference between the two sexes (F(1,33) = 9.12, p = 0.005) and 
an interaction between genotype and sex (F(1,33) = 10.31, p < 
0.01) such that male wildtype mice had a higher water content 
than both male NK1R-/- mice (p < 0.01) and female wildtypes 
(p < 0.001) but the differences were small (ca. 4% and 9.5%, 
respectively) (Figure 3(H)).
Figure 1. (A) Body length (nose to base of tail) (mm), (B) body weight (g) and (C) body mass index (mg/cm2) of male and female NK1R-/- and 
wildtype mice. Mice were weaned onto either standard laboratory chow (Cohort 1) or a high-fat (‘Western’) diet (Cohort 2). N = 8–10 per group. Data 
show mean ± SEM. Solid lines, linking two groups, indicate statistically significant differences of at least p < 0.05.
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Discussion
The neurochemical and behavioural abnormalities expressed by 
NK1R-/- mice have led us to propose that a functional deficit of 
NK1R could contribute to ADHD in patients with polymorphism 
of the TACR1 gene (the human equivalent of Nk1r in rodents) 
(e.g. Yan et al., 2011; see also Sharp et al., 2014). Prompted by 
reports of associations between both small body size and obesity 
with ADHD, we have investigated whether there are differences 
in the body size, body mass and/or composition of NK1R-/- mice 
and their wildtypes that would be consistent with their status as 
a murine analogue of humans with ADHD. This study has 
established that these physical characteristics are abnormal in 
NK1R-/- mice and so, in combination with impaired cognitive 
performance, these factors could serve as biomarkers in transla-
tional studies to help to distinguish ADHD patients with TACR1 
polymorphism(s) from those with ADHD of different aetiology.
The first experiment compared the physical characteristics of 
NK1R-/- and wildtype mice that had been weaned onto normal 
lab chow. Both male and female NK1R-/- mice were approxi-
mately 7% shorter than their wildtypes: the genotype difference 
in male mice was confirmed in the second cohort. This finding 
echoes reports of an association between small body size and 
ADHD (Hanć et al., 2015; Spencer et al., 1996). Hitherto, the 
role of NK1R or substance P on gross physical development has 
not been investigated, but our finding suggests that TACR1 dys-
function could contribute to small body stature in some ADHD 
patients.
Consistent with their small body size, the weight of male 
NK1R-/- mice fed a normal diet was lower (ca.10%) than their 
wildtypes and yet their mBMI did not differ. Moreover, both the 
weight of female NK1R-/- mice and their mBMI body density 
was higher (ca.12%) than their wildtypes. These findings suggest 
that body mass is disproportionally higher than normal in mice 
that lack functional NK1R. This would explain why the tendency 
for small body size of ADHD patients is not necessarily paralleled 
by a lower body weight (Hanć et al., 2015; Spencer et al., 1996).
In Cohort 2, we investigated whether this physical profile was 
also evident when the mice were fed a Western (high-fat) diet. 
Although NK1R-/- males were again shorter than their wildtypes, 
the body weight of the two genotypes of male mice did not differ, 
as was also the case for females. This is reflected by the higher 
mBMI of both male and female NK1R-/- mice, compared with 
their wildtypes.
After correction for body weight, the amount of food con-
sumed by the two genotypes was similar, across all test groups. 
This means that we cannot distinguish whether there is a primary 
increase in food intake by NK1R-/- mice that drives an increase 
in body mass and mBMI, or whether there is a primary metabolic 
disturbance that accounts for both the increase in body mass, 
mBMI and the increase in food intake. Although we cannot rule 
out the former, the latter is more likely in view of the striking 
difference in fat content of NK1R-/- and wildtype mice. Whereas 
the total fat content of female NK1R-/- mice from Cohort 1 was 
more than 17% lower than that of their wildtypes, there was no 
such difference in Cohort 2, which was fed the high-fat diet. 
Furthermore, there was no appreciable difference in the fat con-
tent of males from Cohort 1 and yet the total fat content of male 
NK1R-/- mice from Cohort 2 was 35% higher than that of their 
wildtypes. It seems that, when fed a high-fat diet, fat accumulates 
in both genotypes, but NK1R-/- mice are more prone to fat accu-
mulation than wildtypes: especially the males. Nevertheless, we 
acknowledge that a head-to-head comparison of the two sexes, 
genotypes and diets is needed to confirm this inference.
These differences in fat content of NK1R-/- and wildtype 
mice contrast strikingly with the lack of any appreciable geno-
type differences in protein, water or ash in either males or 
females. Ash comprises the non-combustible material in the car-
cass and is mainly, but not exclusively, derived from bone. As a 
consequence, ash content offers only an approximate index of 
bone mass. Moreover, it was not feasible to measure bone vol-
ume in combination with the techniques used here and so we 
were unable to ascertain whether there were any genotype and / 
or diet induced differences in bone density. As a consequence, 
despite females typically producing more ash than males, we 
cannot infer that this is paralleled by a higher bone mineral den-
sity but this possibility should be considered in any future trans-
lational studies.
The smaller size of NK1R-/- mice on the normal diet would 
explain why they weighed less than the wildtypes, despite their 
higher mBMI. It has been suggested that the association between 
obesity and ADHD is a secondary consequence of features of the 
disorder that will tend to promote food intake and weight gain: 
such as impulsive eating, disruption of feeding architecture or 
impaired neuronal reward circuits (reviewed by Martínez de 
Velasco et al., 2015). It has also been reported that being small 
for gestational age increases the risk of obesity (Grissom and 
Reyes, 2013) and that maternal adiposity and obesity increase 
Figure 2. (a) Time course for weight gain of male and female NK1R-/- 
(KO) and wildtype (WT) mice fed the high-fat diet for 28 days. Male mice 
gained more weight than females, but there was no overall difference 
between the two genotypes for either sex. (b) There was no difference in 
the amount of food consumed after correction for the body weight of the 
mice (mg/g) by the two genotypes and two sexes over the 28 days.
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risk of inattention (Rodriguez, 2010) and ADHD in the offspring 
(Chen et al., 2014; reviewed by Rivera et al., 2015). Obviously, it 
is hard to distinguish the direction of risk causation in these 
human studies. Nevertheless, it would be interesting to carry out 
a head-to-head comparison of the effect of diet on the perfor-
mance of the two genotypes in the 5-CRSTT to test the possibil-
ity that a high-fat diet aggravates ADHD, as has been suggested 
for humans (Howard et al. 2011), for which there is some pre-
clinical supporting evidence (Marwitz et al., 2015). A further 
interesting caveat is that circadian rhythms are disrupted in these 
mice (Porter et al., 2015b) and that disruption of circadian 
rhythms can increase vulnerability to both obesity and ADHD 
(Vogel et al., 2015).
Our findings are consistent with evidence that activation of the 
substance P/NK1R system reduces fat storage by adipocytes in 
vitro (Miegueu et al., 2013) and that substance P promotes lipolysis, 
even if only indirectly (see Ng, 1990). If this is the case, it could 
also help to explain the association between obesity and ADHD 
Figure 3. Body composition (mg/g body weight) of NK1R-/- mice and wildtype male and female mice fed either standard laboratory chow (Cohort 1) 
or a high-fat (‘Western’) diet (Cohort 2). N = 8–10 per group. Data show mean ± SEM. Solid lines, linking two groups indicate statistically significant 
differences of at least p < 0.05. (A, B) Fat; (C, D) protein; (E, F) ash; (G, H) water. The fat content of male NK1R-/- mice from Cohort 2 (given the 
high-fat diet) was higher than that of male wildtypes but did not differ from females of either genotype.
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(Erhart et al., 2012; Pagoto et al., 2009; Waring and Lapane, 2008), 
even in adults (Cortese et al., 2016). By contrast, there are reports 
that administration of the NK1R antagonist,CJ12255, prevents 
weight gain and fat accumulation in male mice given a high-fat 
diet and that of obese ob/ob mice (Karagiannides et al., 2008) or 
allergen-sensitized obese mice (Ramalho et al., 2013). However, 
this drug also reduced food intake, which was not the case for 
NK1R-/- mice in this study, and so a reduction in body weight and 
adiposity could reflect a non-specific response. For example, many 
NK1R antagonists also block L-type Ca2+ channels (see Stanford, 
2014): this leads to a reduction in body weight through augmenta-
tion of thermogenesis, albeit indirectly (Zhao et al., 1999).
The sex differences in both mBMI and fat content on the high-
fat diet are interesting, not least because there are reports that an 
interaction between activation of NK1Rs and sex could influence 
adiposity. For instance, NK1R-mediated stress responses are 
influenced by oestradiol (Bradesi et al., 2003) and there is 
evidence for sexual dimorphism of NK1R expression in many 
tissues (Villablanca and Hanley, 1997). Moreover, a recent 
PET study using the highly selective NK1R [TACR1] ligand, 
[¹¹C]GR205171, found a lower density of NK1Rs in the thalamus 
of women (Engman et al., 2012).
In summary, our findings refine the profile of the NK1R-/- 
mouse phenotype. They indicate that female NK1R-/- mice have 
higher mBMI than wildtypes, regardless of diet, and that a lack of 
functional NK1R in males increases their risk of an excessive 
increase in mBMI and body fat when fed a high-fat (Western) diet. 
These findings highlight the need to incorporate the quality of the 
diet as an experimental variable when comparing genotype differ-
ences in body mass and composition. With that proviso, the find-
ings are consistent with reports of a tendency for unmedicated 
ADHD patients to have higher percentage body fat and shorter 
body stature than other subjects. We have yet to study the cogni-
tive performance and response control of female NK1R-/- mice 
and so do not know whether they are abnormal. However, one 
study does suggest that the females, unlike males, are not hyperac-
tive (Porter et al., 2015a). Nevertheless, our findings lead to the 
prediction that a subset of ADHD patients with TACR1 
polymorphism(s), especially males, would tend to have short stat-
ure, compared with other subjects, and that the males would have 
an increased risk of developing obesity when fed a Western diet.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the 
research, authorship, and/or publication of this article. (SCS is a named 
inventor on an EU patent for the NK1R-/- mouse model of ADHD, but 
declined the option to receive royalties).
Funding
The authors disclosed receipt of the following financial support for the 
research, authorship, and/or publication of this article: This work was 
supported by the Medical Research Council (UK), via an MRC (CASE) 
studentship for KP. The sponsors had no role in the design, implementa-
tion, analysis, or interpretation of the data, in the preparation of the 
manuscript, or in the decision to submit the paper for publication.
References
Agranat-Meged AN, Deitcher C, Goldzweig G, et al. (2005) Child-
hood obesity and attention deficit/hyperactivity disorder: a newly 
described comorbidity in obese hospitalized children. Int J Eating 
Disord 37: 357–359.
Altfas JR (2002) Prevalence of attention deficit/hyperactivity disorder 
among adults in obesity treatment. BMC Psychiatry 2: 9.
Bate ST and Clark RA (2014) The Design and Statistical Analysis of 
Animal Experiments. Cambridge: Cambridge University Press, 
pp.243–248.
Blaine S, Claus E, Harlaar N, et al. (2013) TACR1 genotypes predict 
fMRI response to alcohol cues and level of alcohol dependence. 
Alcohol Clin Exp Res 37(Suppl 1): E125–E130.
Bradesi S, Eutamene H, Garcia-Villar R, et al. (2003) Stress-induced 
visceral hypersensitivity in female rats is estrogen-dependent and 
involves tachykinin NK1 receptors. Pain 102: 227–234.
Byrd HC, Curtin C and Anderson SE (2013) Attention-deficit/hyperac-
tivity disorder and obesity in US males and females, age 8–15 years: 
National Health and Nutrition Examination Survey 2001–2004. 
Pediatr Obesity 8: 445–453.
Chen Q, Sjölander A, Långström N, et al. (2014) Maternal pre-pregnancy 
body mass index and offspring attention deficit hyperactivity dis-
order: a population-based cohort study using a sibling-comparison 
design. Int J Epidemiol 43: 83–90.
Clark RA, Shoaib M, Hewitt KN, et al. (2012) A comparison of InVivo-
Stat with other statistical software packages for analysis of data gen-
erated from animal experiments. J Psychopharmacol 26: 1136–1142.
Cortese S, Moreira-Maia CR, St Fleur D, et al. (2016) Association 
between ADHD and obesity: a systematic review and meta-analysis. 
Am J Psychiatry 173: 34–43.
Cortese S, Ramos Olazagasti MA, Klein RG, et al. (2013) Obesity in men 
with childhood ADHD: a 33-year controlled, prospective, follow-up 
study. Pediatrics 131: e1731–e1738.
Curtin C, Bandini LG, Perrin EC, et al. (2005) Prevalence of overweight 
in children and adolescents with attention deficit hyperactivity dis-
order and autism spectrum disorders: a chart review. BMC Pediatr 
5: 48.
De Felipe C, Herrero JF, O’Brien JA, et al. (1998) Altered nociception, 
analgesia and aggression in mice lacking the receptor for substance 
P. Nature 392: 394–397.
Eisen EJ and Coffey MT (1990) Correlated responses in body composi-
tion based on selection for different indicator traits in mice. J Anim 
Sci 68: 3557–3562.
Engman J, Åhs F, Furmark T, et al. (2012) Age, sex and NK1 receptors in 
the human brain – a positron emission tomography study with [¹¹C]
GR205171. Eur Neuropsychopharmacol 22: 562–568.
Erhart M, Herpertz-Dahlmann B, Wille N, et al. (2012) Examining the 
relationship between attention-deficit/hyperactivity disorder and 
overweight in children and adolescents. Eur Child Adolesc Psychia-
try 21: 39–49.
Fisher AS, Stewart RJ, Yan T, et al. (2007) Disruption of noradrenergic 
transmission and the behavioural response to a novel environment in 
NK1R-/- mice. Eur J Neurosci 25: 1195–1204.
Fleming JP, Levy LD and Levitan RD (2005) Symptoms of attention 
deficit hyperactivity disorder in severely obese women. Eat Weight 
Disord 10: e10–e13.
Grissom NM and Reyes TM (2013) Gestational overgrowth and under-
growth affect neurodevelopment: similarities and differences from 
behavior to epigenetics Int J Dev Neurosci 31: 406–414.
Gürkan K, Bilgiç A, Türkoglu S, et al. ( 2010) Depression, anxiety and 
obsessive-compulsive symptoms and quality of life in children with 
attention-deficit hyperactivity disorder (ADHD) during three-month 
methylphenidate treatment. J Psychopharmacol 24: 1810–1818.
Hanć T, Słopień A, Wolańczyk T, et al. (2015) Attention-deficit/hyperac-
tivity disorder is related to decreased weight in the preschool period 
and to increased rate of overweight in school-age boys. J Child Ado-
lesc Psychopharmacol 25: 691–700.
Herpfer I, Hunt SP and Stanford SC (2005) A comparison of neuroki-
nin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory 
behaviour and extracellular noradrenaline concentration in the 
cerebral cortex of anaesthetised subjects. Neuropharmacology 48: 
706–719.
 at University College London on September 26, 2016jop.sagepub.comDownloaded from 
Pillidge et al. 855
Howard AL, Robinson M, Smith GJ, et al. (2011) ADHD is associated 
with a “Western” dietary pattern in adolescents. J Attent Disord 15: 
403–411.
Hubel R, Jass J, Marcus A, et al. (2006) Overweight and basal metabolic 
rate in boys with attention-deficit/hyperactivity disorder. Eat Weight 
Disord 11: 139–146.
Karagiannides I, Torres D, Tseng YH, et al. (2008) Substance P as a 
novel anti-obesity target. Gastroenterology 134: 747–755.
Kim J, Mutyala B, Agiovlasitis S, et al. (2011) Health behaviors and obe-
sity among US children with attention deficit hyperactivity disorder 
by gender and medication use. Prev Med 52: 218–222.
Martínez de Velasco R, Barbudo E, Pérez-Templado J, et al. (2015) 
Review of the association between obesity and ADHD. Actas Espa-
ñolas Psiquiatría 43: 16–23.
Marwitz SE, Woodie LN and Blythe SN (2015) Western-style diet 
induces insulin insensitivity and hyperactivity in adolescent male 
rats. Physiol Behav 151: 147–154.
Mick E, Biederman J, Prince J, et al. (2002) Impact of low birth weight 
on attention-deficit hyperactivity disorder. J Dev Behav Pediatr 23: 
16–22.
Miegueu P, St-Pierre DH, Lapointe M, et al. (2013) Substance P decreases 
fat storage and increases adipocytokine production in 3T3-L1 adipo-
cytes. Am J Gastrointest Liver Physiol 304: G420–G427.
Moyes AJ, Stanford SC, Hosford PS, et al. (2016) Raised arterial blood 
pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evi-
dence for a neural rather than a vascular mechanism. Exp Physiol 
101: 588–598.
Ng TB (1990) Studies on hormonal regulation of lipolysis and lipogene-
sis in fat cells of various mammalian species. Comp Biochem Physiol 
B 97: 441–446.
Pagoto SL, Curtin C, Lemon SC, et al. (2009) Association between adult 
attention deficit/hyperactivity disorder and obesity in the US popula-
tion. Obesity 17: 539–544.
Pillidge K, Porter AJ, Dudley JA, et al. (2014a) The behavioural response 
of mice lacking NK₁ receptors to guanfacine resembles its clinical 
profile in treatment of ADHD. Br J Pharmacol 171: 4785–4796.
Pillidge K, Porter AJ, Vasili T, et al. (2014b) Atomoxetine reduces 
hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knock-
out’ mice. Pharmacol Biochem Behav 127: 56–61.
Pillidge K, Porter AJ, Young JW, et al. (2016) Perseveration by NK1R-/- 
(‘knockout’) mice is blunted by doses of methylphenidate that affect 
neither other aspects of their cognitive performance nor the behav-
iour of wild-type mice in the 5-Choice Continuous Performance 
Test. J Psychopharmacol 30(9): 837–847.
Porter AJ, Pillidge K, Grabowska EM, et al. (2015a) The angiotensin 
converting enzyme inhibitor, captopril, prevents the hyperactiv-
ity and impulsivity of neurokinin-1 receptor gene ‘knockout’ 
mice: sex differences and implications for the treatment of atten-
tion deficit hyperactivity disorder. Eur Neuropsychopharmacol 25: 
512–521.
Porter AJ, Pillidge K, Stanford SC, et al. (2016) Differences in the perfor-
mance of NK1R-/- (‘knockout’) and wildtype mice in the 5-Choice 
Continuous Performance Test. Behav Brain Res 298: 268–277.
Porter AJ, Pillidge K, Tsai YC, et al. (2015b) A lack of functional NK1 
receptors explains most, but not all, abnormal behaviours of NK1R-/- 
mice. Genes Brain Behav 14: 189–199.
Ptacek R, Kuzelova H, Paclt I, et al. (2009) ADHD and growth: anthropo-
metric changes in medicated and non-medicated ADHD boys. Med 
Sci Monitor 15: CR595–CR599.
Ramalho R, Almeida J, Beltrão M, et al. (2013) Substance P antagonist 
improves both obesity and asthma in a mouse model. Allergy 68: 
48–54.
Rivera HM, Christiansen KJ and Sullivan EL (2015) The role of maternal 
obesity in the risk of neuropsychiatric disorders. Front Neurosci 9: 194.
Rodriguez A (2010) Maternal pre-pregnancy obesity and risk for inatten-
tion and negative emotionality in children. J Child Psychol Psychia-
try 51: 134–143.
Sharp SI, McQuillin A, Marks M, et al. (2014) Genetic association of 
the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention 
deficit hyperactivity disorder, and the alcohol dependence syndrome. 
Am J Med Genet Part B Neuropsychiatr Genet 165: 373–380.
Spencer TJ, Biederman J, Harding M, et al. (1996) Growth deficits in 
ADHD children revisited: evidence for disorder-associated growth 
delays? J Am Acad Child Adolesc Psychiatry 35: 1460–1469.
Stanford SC (2014) Psychostimulants, antidepressants and neurokinin-1 
receptor antagonists (‘motor disinhibitors’) have overlapping, but 
distinct, effects on monoamine transmission: the involvement of 
L-type Ca2+ channels and implications for the treatment of ADHD. 
Neuropharmacology 87: 9–18.
Van Egmond-Fröhlich AW, Widhalm K and de Zwaan M (2012) Asso-
ciation of symptoms of attention-deficit/hyperactivity disorder with 
childhood overweight adjusted for confounding parental variables. 
Int J Obesity 36: 963–968.
Villablanca AC and Hanley MR (1997) 17beta-estradiol stimulates sub-
stance P receptor gene expression. Mol Cell Endocrinol 135: 109–117.
Vogel SW, Bijlenga D, Tanke M, et al. (2015) Circadian rhythm disrup-
tion as a link between attention-deficit/hyperactivity disorder and 
obesity? J Psychosomatic Res 79: 443–450.
Waring ME and Lapane KL (2008) Overweight in children and adoles-
cents in relation to attention-deficit/hyperactivity disorder: results 
from a national sample. Pediatrics 122: e1–e6.
Yan TC, Dudley JA, Weir RK, et al. (2011) Performance deficits of 
NK1 receptor knockout mice in the 5-choice serial reaction-time 
task: effects of d-amphetamine, stress and time of day. PLoS One 
6: e17586.
Yan TC, Hunt SP and Stanford SC (2009) Behavioural and neurochemi-
cal abnormalities in mice lacking functional tachykinin-1 (NK1) 
receptors: a model of attention deficit hyperactivity disorder. Neuro-
pharmacology 57: 627–635.
Yan TC, McQuillin A, Thapar A, et al. (2010) NK1 (TACR1) receptor 
gene ‘knockout’ mouse phenotype predicts genetic association with 
ADHD. J Psychopharmacol 24: 27–38.
Zhao J, Golozoubova V, Bengtsson T, et al. (1999) Benidipine induces 
thermogenesis in brown adipose tissue by releasing endogenous 
noradrenaline: a possible mechanism for the anti-obesity effect of 
calcium antagonists. Int J Obesity Relat Metab Disord 23: 238–245.
 at University College London on September 26, 2016jop.sagepub.comDownloaded from 
